Announcement of launch, break or close-out of marketing of a medicinal product

The database includes reports since 31st December 2007, date of effect of the Act No 378/2007 Coll., stipulating the obligation of marketing authorisation holders to report launch, suspension or withdrawal from the market of a medicinal product to SÚKL

Search

 

   

   

Number of records: 10
SÚKL code Name of medicinal product Supplement of name Type of announcement Effective date Alternate medicines 1)
Estimated renewal date Reason for interruption/cessation of marketing
0199684 TERFIMED 250MG TBL NOB 14 II Resumption of marketing 21.06.2018
0199685 TERFIMED 250MG TBL NOB 28 II Resumption of marketing 21.06.2018
0199684 TERFIMED 250MG TBL NOB 14 II Interruption of marketing 24.04.2018 0001421
0199685 TERFIMED 250MG TBL NOB 28 II Interruption of marketing 14.03.2018 0001421, 0199684
0199684 TERFIMED 250MG TBL NOB 14 II Placing on the market 29.07.2013
0106144 TERFIMED 250MG TBL NOB 14 I Cessation of marketing 26.07.2013 0102518, 0001421
0199685 TERFIMED 250MG TBL NOB 28 II Placing on the market 27.06.2013
0106145 TERFIMED 250MG TBL NOB 28 I Cessation of marketing 03.06.2013 0102518, 0106144, 0001421
0106144 TERFIMED 250MG TBL NOB 14 I Placing on the market 01.10.2008
0106145 TERFIMED 250MG TBL NOB 28 I Placing on the market 01.10.2008
1) The review shows only medicinal products with active incidence on the Czech market (based on regular reports of supplies of distributed human medicinal products in the previous quarter).

Medicinal products reimbursed from health insurance are marked in color.
Last database update: 17. May 2021 v 14:30